<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Trofinetide</id>
	<title>Trofinetide - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Trofinetide"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Trofinetide&amp;action=history"/>
	<updated>2026-04-27T03:55:21Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Trofinetide&amp;diff=4963569&amp;oldid=prev</id>
		<title>Deepika vegiraju at 08:13, 12 June 2023</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Trofinetide&amp;diff=4963569&amp;oldid=prev"/>
		<updated>2023-06-12T08:13:47Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== &amp;#039;&amp;#039;&amp;#039;What is Trofinetide?&amp;#039;&amp;#039;&amp;#039; ==&lt;br /&gt;
&lt;br /&gt;
* Trofinetide (&amp;#039;&amp;#039;&amp;#039;Daybue&amp;#039;&amp;#039;&amp;#039;), is &amp;#039;&amp;#039;&amp;#039;an analog of glycine-proline-glutamate (GPE)&amp;#039;&amp;#039;&amp;#039;, a protein that occurs naturally in the brain. &lt;br /&gt;
&lt;br /&gt;
[[File:Trofinetide.svg|thumb|Trofinetide]]&lt;br /&gt;
&lt;br /&gt;
[[File:Trofinetide structure.png|thumb|Trofinetide structure]]&lt;br /&gt;
&lt;br /&gt;
&amp;lt;youtube&amp;gt;&lt;br /&gt;
title=&amp;#039;&amp;#039;&amp;#039;{{PAGENAME}}&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
movie_url=http://www.youtube.com/v/v=QzwoIvlnqgc&lt;br /&gt;
embed_source_url=http://www.youtube.com/v/v=QzwoIvlnqgc&lt;br /&gt;
&amp;amp;rel=1&lt;br /&gt;
wrap = yes&lt;br /&gt;
width=750&lt;br /&gt;
height=600&lt;br /&gt;
&amp;lt;/youtube&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== &amp;#039;&amp;#039;&amp;#039;What are the uses of this medicine?&amp;#039;&amp;#039;&amp;#039; ==&lt;br /&gt;
&lt;br /&gt;
* Trofinetide (&amp;#039;&amp;#039;&amp;#039;Daybue&amp;#039;&amp;#039;&amp;#039;) is a prescription medicine used to treat [[Rett syndrome]] in adults and children 2 years of age and older.&lt;br /&gt;
&lt;br /&gt;
== &amp;#039;&amp;#039;&amp;#039;How does this medicine work?&amp;#039;&amp;#039;&amp;#039; ==&lt;br /&gt;
&lt;br /&gt;
* The mechanism by which trofinetide exerts therapeutic effects in patients with Rett syndrome is unknown.&lt;br /&gt;
&lt;br /&gt;
== &amp;#039;&amp;#039;&amp;#039;Who Should Not Use this medicine ?&amp;#039;&amp;#039;&amp;#039; ==&lt;br /&gt;
&lt;br /&gt;
* This medicine have no usage limitations.&lt;br /&gt;
&lt;br /&gt;
== &amp;#039;&amp;#039;&amp;#039;What drug interactions can this medicine cause?&amp;#039;&amp;#039;&amp;#039; ==&lt;br /&gt;
&lt;br /&gt;
* Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.&lt;br /&gt;
* Your doctor may need to change the doses of your medications or monitor you carefully for side effects.&lt;br /&gt;
&lt;br /&gt;
Be sure to mention any of the following:&lt;br /&gt;
* [[laxatives]]&lt;br /&gt;
* Orally administered CYP3A4 sensitive substrates&lt;br /&gt;
* OATP1B1 and OATP1B3 substrates&lt;br /&gt;
&lt;br /&gt;
== &amp;#039;&amp;#039;&amp;#039;Is this medicine FDA approved?&amp;#039;&amp;#039;&amp;#039; ==&lt;br /&gt;
&lt;br /&gt;
* Trofinetide was approved for medical use in the United States in March 2023.&lt;br /&gt;
&lt;br /&gt;
== &amp;#039;&amp;#039;&amp;#039;How should this medicine be used?&amp;#039;&amp;#039;&amp;#039; ==&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Recommended dosage:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
Administer Daybue orally twice daily, in the morning and evening, according to patient weight as shown:&lt;br /&gt;
* 9 kg to less than 12 kg: 5,000 mg twice daily(25 mL twice daily)&lt;br /&gt;
* 12 kg to less than 20 kg: 6,000 mg twice daily(30 mL twice daily)&lt;br /&gt;
* 20 kg to less than 35 kg: 8,000 mg twice daily(40 mL twice daily)&lt;br /&gt;
* 35 kg to less than 50 kg: 10,000 mg twice daily	(50 mL twice daily)&lt;br /&gt;
* 50 kg or more: 12,000 mg twice daily (60 mL twice daily)&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Administration:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Take Daybue exactly as your healthcare provider tells you to take it.&lt;br /&gt;
* If you take laxatives, stop taking them before starting treatment with Daybue.&lt;br /&gt;
* Your healthcare provider may change your dose or stop treatment with Daybue if needed.&lt;br /&gt;
* Your pharmacist should provide an oral syringe or dosing cup that is needed to measure your prescribed dose. Do not use a household measuring cup.&lt;br /&gt;
* Daybue may be taken by mouth or given through a gastrostomy (G) tube. If Daybue is given through a gastrojejunal (GJ) tube, the G-port must be used.&lt;br /&gt;
* Daybue may be taken with or without food.&lt;br /&gt;
* Throw away any unused Daybue after 14 days of first opening the bottle.&lt;br /&gt;
* If you vomit after taking a dose of Daybue, do not take another dose to make up for that dose. Wait and take the next dose at your usual time.&lt;br /&gt;
* If you miss a dose of Daybue, skip that dose and take your next dose at your usual time. Do not take 2 doses to make up the missed dose.&lt;br /&gt;
&lt;br /&gt;
== &amp;#039;&amp;#039;&amp;#039;What are the  dosage forms and brand names of this medicine?&amp;#039;&amp;#039;&amp;#039; ==&lt;br /&gt;
&lt;br /&gt;
This medicine is available in fallowing doasage form:&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;As Oral solution:&amp;#039;&amp;#039;&amp;#039; 200 mg/mL&lt;br /&gt;
&lt;br /&gt;
This medicine is available in fallowing brand namesː&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Daybue&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
==&amp;#039;&amp;#039;&amp;#039;What side effects can this medication cause?&amp;#039;&amp;#039;&amp;#039;==&lt;br /&gt;
&lt;br /&gt;
The most common side effects of this medicine include:&lt;br /&gt;
* [[Diarrhea]]&lt;br /&gt;
* Vomiting&lt;br /&gt;
* Fever&lt;br /&gt;
* [[Seizure]]	&lt;br /&gt;
* [[Anxiety]]&lt;br /&gt;
* Decreased appetite&lt;br /&gt;
* [[Fatigue]]&lt;br /&gt;
* [[Nasopharyngitis]]&lt;br /&gt;
&lt;br /&gt;
Less common, but serious side effects may include:&lt;br /&gt;
* [[Diarrhea]]&lt;br /&gt;
* Weight loss&lt;br /&gt;
&lt;br /&gt;
==&amp;#039;&amp;#039;&amp;#039; What special precautions should I follow?&amp;#039;&amp;#039;&amp;#039; ==&lt;br /&gt;
&lt;br /&gt;
* Most patients experience [[diarrhea]] during treatment with Daybue. Advise patients to stop [[laxatives]] before starting Daybue. If diarrhea occurs, patients should start [[antidiarrheal]] treatment, increase oral fluids, and notify their healthcare provider. Interrupt, reduce dose, or discontinue Daybue if severe diarrhea occurs or if [[dehydration]] is suspected.&lt;br /&gt;
* Weight loss may occur in patients treated with Daybue. Monitor weight and interrupt, reduce dose, or discontinue Daybue if significant weight loss occurs.&lt;br /&gt;
* Advise the caregiver or patient that Daybue can cause vomiting and if vomiting occurs after Daybue administration, do not take an additional dose, but continue with the next scheduled dose.&lt;br /&gt;
* Advise the caregiver or patient that Daybue may be given orally or via [[gastrostomy]] (G) tube; doses administered via gastrojejunal (GJ) tubes must be administered through the G-port. Daybue may be taken with or without food.&lt;br /&gt;
* Instruct the caregiver or patient to obtain a calibrated measuring device, such as an oral syringe or oral dosing cup, from the pharmacy to measure and deliver the prescribed dose accurately. A household measuring cup is not an adequate measuring device.&lt;br /&gt;
* Instruct the caregiver or patient to discard any unused Daybue after 14 days of first opening the bottle.&lt;br /&gt;
* It is not known if Daybue passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby while taking Daybue.&lt;br /&gt;
&lt;br /&gt;
== &amp;#039;&amp;#039;&amp;#039;What to do in case of emergency/overdose?&amp;#039;&amp;#039;&amp;#039; ==&lt;br /&gt;
&lt;br /&gt;
* {{overdose}}&lt;br /&gt;
&lt;br /&gt;
== &amp;#039;&amp;#039;&amp;#039;Can this medicine be used in pregnancy?&amp;#039;&amp;#039;&amp;#039; ==&lt;br /&gt;
&lt;br /&gt;
* There are no adequate data on the developmental risks associated with the use of Daybue in pregnant women.&lt;br /&gt;
* It is not known if Daybue will harm your unborn baby.&lt;br /&gt;
&lt;br /&gt;
==&amp;#039;&amp;#039;&amp;#039;Can this medicine be used in children?&amp;#039;&amp;#039;&amp;#039;==&lt;br /&gt;
&lt;br /&gt;
* The safety and effectiveness of Daybue for the treatment of Rett syndrome have been established in pediatric patients aged 2 years and older. &lt;br /&gt;
* Safety and effectiveness in pediatric patients less than 2 years of age have not been established.&lt;br /&gt;
&lt;br /&gt;
== &amp;#039;&amp;#039;&amp;#039;What are the active and inactive ingredients in this medicine?&amp;#039;&amp;#039;&amp;#039; ==&lt;br /&gt;
&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Active ingredient:&amp;#039;&amp;#039;&amp;#039; trofinetide&lt;br /&gt;
* &amp;#039;&amp;#039;&amp;#039;Inactive ingredients:&amp;#039;&amp;#039;&amp;#039; FD&amp;amp;C Red No. 40, maltitol, methylparaben sodium, propylparaben sodium, purified water, strawberry flavor, and sucralose.&lt;br /&gt;
&lt;br /&gt;
== &amp;#039;&amp;#039;&amp;#039;Who manufactures and distributes this medicine?&amp;#039;&amp;#039;&amp;#039; ==&lt;br /&gt;
&lt;br /&gt;
* Marketed by [[Acadia Pharmaceuticals Inc.]], San Diego, CA, USA&lt;br /&gt;
* Daybue is a trademark of Acadia Pharmaceuticals Inc.&lt;br /&gt;
&lt;br /&gt;
== &amp;#039;&amp;#039;&amp;#039;What should I know about storage and disposal of this medication?&amp;#039;&amp;#039;&amp;#039; ==&lt;br /&gt;
&lt;br /&gt;
* Store Daybue in the refrigerator between 36°F to 46°F (2°C to 8°C). Do not freeze.&lt;br /&gt;
* Keep Daybue in an upright position.&lt;br /&gt;
* Keep the child-resistant cap tightly closed.&lt;br /&gt;
&lt;br /&gt;
{{coststubd}}&lt;br /&gt;
{{Growth factor receptor modulators}}&lt;br /&gt;
{{Portal bar | Medicine}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Anti-inflammatory agents]]&lt;br /&gt;
[[Category:Tripeptides]]&lt;/div&gt;</summary>
		<author><name>Deepika vegiraju</name></author>
	</entry>
</feed>